Literature DB >> 24214318

The unmet need for philanthropic funding of early career cardiovascular investigators.

Tariq Ahmad1, Richard C Becker.   

Abstract

Philanthropic donations have funded scientific investigations of cardiovascular disease for much of human history, and the patrons who enabled them are indirectly responsible for major breakthroughs in the field. Today, however, the lion's share of funding for cardiovascular research in Western countries comes from the government, professional agencies, and industry. Rapid budget cuts at these traditional sources of financial support are having a devastating impact on the cardiovascular research infrastructure by slashing funding for investigators. A particularly unfortunate consequence is the discouraging effect this is having on early career investigators, who are the life-blood of future breakthroughs in the field, leading to the potential loss of an entire generation of researchers. Here, we summarize the challenges faced by emerging cardiovascular investigators, make a case for the unmet need for appropriately targeted philanthropic support for cardiovascular research, and provide a roadmap for solving the funding shortfall for these investigators.

Entities:  

Mesh:

Year:  2014        PMID: 24214318     DOI: 10.1007/s11239-013-1016-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  12 in total

1.  A tale of coronary artery disease and myocardial infarction.

Authors:  Elizabeth G Nabel; Eugene Braunwald
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

2.  Research funding. NIH in the post-doubling era: realities and strategies.

Authors:  Elias A Zerhouni
Journal:  Science       Date:  2006-11-17       Impact factor: 47.728

Review 3.  Academic careers in cardiovascular medicine.

Authors:  Valentin Fuster; Sarina van der Zee; Sammy Elmariah; Robert O Bonow
Journal:  Circulation       Date:  2009-02-10       Impact factor: 29.690

4.  The future of research funding in academic medicine.

Authors:  Eric G Campbell
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

Review 5.  The productivity crisis in pharmaceutical R&D.

Authors:  Fabio Pammolli; Laura Magazzini; Massimo Riccaboni
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

6.  The magnitude and nature of unfunded published cardiovascular research.

Authors:  Tuan V Mai; Donna L Agan; Paul Clopton; Glenn Collins; Anthony N DeMaria
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

Review 7.  The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology.

Authors:  Lawrence J Laslett; Peter Alagona; Bernard A Clark; Joseph P Drozda; Frances Saldivar; Sean R Wilson; Chris Poe; Menolly Hart
Journal:  J Am Coll Cardiol       Date:  2012-12-25       Impact factor: 24.094

8.  Funding of US biomedical research, 2003-2008.

Authors:  E Ray Dorsey; Jason de Roulet; Joel P Thompson; Jason I Reminick; Ashley Thai; Zachary White-Stellato; Christopher A Beck; Benjamin P George; Hamilton Moses
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

9.  The grand challenges in cardiovascular drug discovery and development.

Authors:  Eliot H Ohlstein
Journal:  Front Pharmacol       Date:  2010-09-23       Impact factor: 5.810

10.  The impact of National Institutes of Health funding on U.S. cardiovascular disease research.

Authors:  Radmila Lyubarova; Brandon K Itagaki; Michael W Itagaki
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.